tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
GT Biopharma's activity chart (see below) currently has 9 price targets and 12 ratings on display.
Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 249.67 days.
Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 08-Aug-2023. First documented stock forecast 17-Mar-2021.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 13-Sep-2022
$5
$-3.61 (-41.93%)
$5
3 years 1 months 8 days ago
(08-Aug-2023)
5/5 (100%)
$-3.64 (-42.13%)
228
Hold Since 05-Jan-2023
$2
$-6.61 (-76.77%)
$2
3 years 1 months 9 days ago
(07-Aug-2023)
4/4 (100%)
$-6.4 (-76.19%)
521
Buy
$26
$25.74 (9900.00%)
5 years 2 months 23 days ago
(24-Jun-2021)
0/1 (0%)
$11.72 (82.07%)
What is GTBP (GT Biopharma) average time for price targets to be met?
Which analyst most recently updated their price target on GTBP (GT Biopharma)?
Which analyst has the current lower performing score on GTBP (GT Biopharma) with a proven track record?
Which analyst has the most public recommendations on GTBP (GT Biopharma)?
Which analyst is the currently most bullish on GTBP (GT Biopharma)?
Which analyst is the currently most reserved on GTBP (GT Biopharma)?
